Literature DB >> 16651320

Predictors of fatality in postdiarrheal hemolytic uremic syndrome.

Robert S Oakes1, Richard L Siegler, Markham A McReynolds, Theodore Pysher, Andrew T Pavia.   

Abstract

OBJECTIVES: Describe the cause of deaths among patients with postdiarrheal hemolytic uremic syndrome (HUS) and identify predictors of death at the time of hospital admission.
METHODS: Case-control study of 17 deaths among patients with HUS identified from the Intermountain HUS Patient Registry (1970-2003) compared against all nonfatal cases.
RESULTS: Of the 17 total deaths, 15 died during the acute phase of disease. Two died because treatment was withdrawn based on their preexisting conditions, and 1 died because of iatrogenic cardiac tamponade; they were excluded from analysis. Brain involvement was the most common cause of death (8 of 12); congestive heart failure, pulmonary hemorrhage, and hyperkalemia were infrequent causes. Presence of prodromal lethargy, oligoanuria, or seizures and white blood cell count (WBC) >20 x 10(9)/L or hematocrit >23% on admission were predictive of death. In multivariate analysis, elevated WBC and elevated hematocrit were independent predictors. The combination of prodromal dehydration, oliguria, and lethargy and admission WBC values >20 x 10(9)/L and hematocrit >23% appeared in 7 of the 12 acute-phase deaths.
CONCLUSIONS: Diarrheal HUS patients presenting with oligoanuria, dehydration, WBC >20 x 10(9)/L, and hematocrit >23% are at substantial risk for fatal hemolytic uremic syndrome. Such individuals should be referred to pediatric tertiary care centers.

Entities:  

Mesh:

Year:  2006        PMID: 16651320     DOI: 10.1542/peds.2005-0785

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  39 in total

1.  Hemoconcentration in hemolytic uremic syndrome: time to review the standard case definition?

Authors:  Alejandro Balestracci; Sandra Mariel Martin; Ismael Toledo
Journal:  Pediatr Nephrol       Date:  2014-10-26       Impact factor: 3.714

2.  Clinical characteristics and long-term outcome of diarrhea-associated hemolytic uremic syndrome: a single center experience.

Authors:  Takeshi Ninchoji; Kandai Nozu; Keita Nakanishi; Tomoko Horinouchi; Junya Fujimura; Tomohiko Yamamura; Shogo Minamikawa; Shingo Ishimori; Koichi Nakanishi; Norishige Yoshikawa; Ichiro Morioka; Hiroshi Kaito; Kazumoto Iijima
Journal:  Clin Exp Nephrol       Date:  2017-01-10       Impact factor: 2.801

3.  A simple prognostic index for Shigatoxin-related hemolytic uremic syndrome at onset: data from the ItalKid-HUS network.

Authors:  Gianluigi Ardissino; Francesca Tel; Sara Testa; Fabio Paglialonga; Selena Longhi; Laura Martelli; Silvia Consolo; Damiano Picicco; Antonella Dodaro; Laura Daprai; Rosaria Colombo; Milena Arghittu; Michela Perrone; Giovanna Chidini; Stefano Scalia Catenacci; Isabella Cropanese; Dario Consonni
Journal:  Eur J Pediatr       Date:  2018-08-10       Impact factor: 3.183

4.  Dehydration at admission increased the need for dialysis in hemolytic uremic syndrome children.

Authors:  Alejandro Balestracci; Sandra Mariel Martin; Ismael Toledo; Caupolican Alvarado; Raquel Eva Wainsztein
Journal:  Pediatr Nephrol       Date:  2012-04-03       Impact factor: 3.714

Review 5.  Guidelines for the management and investigation of hemolytic uremic syndrome.

Authors:  Takashi Igarashi; Shuichi Ito; Mayumi Sako; Akihiko Saitoh; Hiroshi Hataya; Masashi Mizuguchi; Tsuneo Morishima; Kenji Ohnishi; Naohisa Kawamura; Hirotsugu Kitayama; Akira Ashida; Shinya Kaname; Hiromichi Taneichi; Julian Tang; Makoto Ohnishi
Journal:  Clin Exp Nephrol       Date:  2014-08       Impact factor: 2.801

6.  Hemoconcentration: a major risk factor for neurological involvement in hemolytic uremic syndrome.

Authors:  Gianluigi Ardissino; Valeria Daccò; Sara Testa; Cristina Felice Civitillo; Francesca Tel; Ilaria Possenti; Mirco Belingheri; Pierangela Castorina; Nicolò Bolsa-Ghiringhelli; Silvana Tedeschi; Fabio Paglialonga; Stefania Salardi; Dario Consonni; Elena Zoia; Patrizia Salice; Giovanna Chidini
Journal:  Pediatr Nephrol       Date:  2014-08-23       Impact factor: 3.714

7.  Impact of platelet transfusions in children with post-diarrheal hemolytic uremic syndrome.

Authors:  Alejandro Balestracci; Sandra Mariel Martin; Ismael Toledo; Caupolican Alvarado; Raquel Eva Wainsztein
Journal:  Pediatr Nephrol       Date:  2013-02-06       Impact factor: 3.714

8.  Enterohemorrhagic colitis with disseminated intravascular coagulation.

Authors:  Gregory Taroyan; Andrew L Juergens
Journal:  Proc (Bayl Univ Med Cent)       Date:  2018-05-14

Review 9.  HUS and TTP in Children.

Authors:  Howard Trachtman
Journal:  Pediatr Clin North Am       Date:  2013-12       Impact factor: 3.278

Review 10.  Long-term outcomes of Shiga toxin hemolytic uremic syndrome.

Authors:  Joann M Spinale; Rebecca L Ruebner; Lawrence Copelovitch; Bernard S Kaplan
Journal:  Pediatr Nephrol       Date:  2013-01-04       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.